8-K
filed October 14, 2025, 7:59 PM ET
ticker ALLO
CIK 0001737287
litigation
confidence high
sentiment negative
materiality 0.65
Allogene reports patent infringement lawsuit against licensor Cellectis by Factor Bioscience
Allogene Therapeutics, Inc.
- Factor Bioscience filed a complaint in Delaware against Cellectis and AstraZeneca on Sept 26, 2025, alleging TALEN gene-editing patent infringement.
- Allogene relies on Cellectis's TALEN technology for allogeneic CAR T candidates including cema-cel and ALLO-316.
- Cellectis notified Allogene on October 6, 2025, and intends to vigorously defend against the claims.
- Factor may also assert direct claims against Allogene as a commercial user of the disputed technology.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001628280-25-044828
- form_type
- 8-K
- ticker
- ALLO
- cik
- 0001737287
- company_name
- Allogene Therapeutics, Inc.
- filed_at
- 2025-10-14T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:40.282255+00:00
- generated_at
- 2026-05-17T03:56:36.931481+00:00
- sec_items
- ["8.01"]
- event_type
- litigation
- sentiment
- negative
- materiality_score
- 0.65
- calibrated_materiality_score
- 0.65
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001628280-25-044828
- json_url
- https://secwatch.observer/filing/0001628280-25-044828.json
- markdown_url
- https://secwatch.observer/filing/0001628280-25-044828.md
- text_url
- https://secwatch.observer/filing/0001628280-25-044828.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1737287/000162828025044828/0001628280-25-044828-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1737287/000162828025044828/allo-20250926.htm
- generated_by_model
- deepseek-v4-flash:cloud
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
SAM
Boston Beer Co. gets $191M final judgement in Ardagh suit; interest lowered $21M
BOSTON BEER CO INC
June 1, 2026, 4:10 PM ET
litigation
Items 8.01
same SEC item: 8.01
same event type: litigation
similar materiality
Filing page
SEC filing
PPTA
Court denies preliminary injunction against Perpetua's Stibnite Gold Project; construction resumes
PERPETUA RESOURCES CORP.
June 1, 2026, 7:40 AM ET
litigation
Items 8.01
same SEC item: 8.01
same event type: litigation
similar materiality
Filing page
SEC filing
EXPI
Court grants preliminary approval of eXp's opt-in settlement in buyer-broker commission class action
eXp World Holdings, Inc.
May 29, 2026, 5:00 PM ET
litigation
Items 8.01
same SEC item: 8.01
same event type: litigation
similar materiality
Filing page
SEC filing
BNC
CEA Industries files suit against 10X Capital to void asset management agreement as unconscionable
CEA Industries Inc.
May 29, 2026, 4:10 PM ET
litigation
Items 8.01, 9.01
same SEC item: 8.01
same event type: litigation
similar materiality
Filing page
SEC filing
SPCE
Virgin Galactic derivative suit settlement preliminarily approved; $2.75M from insurers
Virgin Galactic Holdings, Inc
May 28, 2026, 5:10 PM ET
litigation
Items 7.01, 8.01, 9.01
same SEC item: 8.01
same event type: litigation
similar materiality
Filing page
SEC filing
NUAI
New Era Energy & Digital settles NM lawsuit for $1M; denies liability
New ERA Energy & Digital, Inc.
May 28, 2026, 4:22 PM ET
litigation
Items 7.01, 8.01, 9.01
same SEC item: 8.01
same event type: litigation
similar materiality
Filing page
SEC filing
RYES
Rise Gold subsidiary loses summary judgment in Clean Water Act suit; disputes ruling
Rise Gold Corp.
May 22, 2026, 5:26 PM ET
litigation
Items 8.01, 9.01
same SEC item: 8.01
same event type: litigation
similar materiality
Filing page
SEC filing
CRDF
Cardiff Oncology sues Nerviano Medical Sciences over onvansertib license inventorship dispute
Cardiff Oncology, Inc.
May 19, 2026, 5:01 PM ET
litigation
Items 8.01
same SEC item: 8.01
same event type: litigation
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.